{"id":"https://openalex.org/W1526328115","doi":"https://doi.org/10.1023/a:1018947208597","title":"Indirect Evidence that Drug Brain Targeting Using Polysorbate 80-Coated Polybutylcyanoacrylate Nanoparticles Is Related to Toxicity","display_name":"Indirect Evidence that Drug Brain Targeting Using Polysorbate 80-Coated Polybutylcyanoacrylate Nanoparticles Is Related to Toxicity","publication_year":1999,"publication_date":"1999-12-01","ids":{"openalex":"https://openalex.org/W1526328115","doi":"https://doi.org/10.1023/a:1018947208597","mag":"1526328115","pmid":"https://pubmed.ncbi.nlm.nih.gov/10644071"},"language":"en","primary_location":{"id":"doi:10.1023/a:1018947208597","doi":"https://doi.org/10.1023/a:1018947208597","is_oa":false,"landing_page_url":"https://doi.org/10.1023/a:1018947208597","pdf_url":null,"source":{"id":"https://openalex.org/S103865650","display_name":"Pharmaceutical Research","issn_l":"0724-8741","issn":["0724-8741","1573-904X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-70","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319900","host_organization_name":"Springer Science+Business Media","host_organization_lineage":["https://openalex.org/P4310319900","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Science+Business Media","Springer Nature"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pharmaceutical Research","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5102751761","display_name":"Jean\u2010Christophe Olivier","orcid":"https://orcid.org/0000-0002-9116-4400","observed_orcids":["https://orcid.org/0000-0002-9116-4400"]},"institutions":[{"id":"https://openalex.org/I32881790","display_name":"Universit\u00e9 de Poitiers","ror":"https://ror.org/04xhy8q59","country_code":"FR","type":"education","lineage":["https://openalex.org/I32881790"]}],"countries":["FR"],"is_corresponding":true,"raw_author_name":"Jean-Christophe Olivier","raw_affiliation_strings":["Laboratoire de Pharmacie Gal\u00e9nique et Biopharmacie UPRES EA 1223 34, Poitiers, France. jc.olivier@campus.univ-poitiers.fr","Laboratoire de Pharmacie Gal\u00e9nique et Biopharmacie UPRES EA 1223, Poitiers, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Laboratoire de Pharmacie Gal\u00e9nique et Biopharmacie UPRES EA 1223 34, Poitiers, France. jc.olivier@campus.univ-poitiers.fr","institution_ids":["https://openalex.org/I32881790"]},{"raw_affiliation_string":"Laboratoire de Pharmacie Gal\u00e9nique et Biopharmacie UPRES EA 1223, Poitiers, France","institution_ids":["https://openalex.org/I32881790"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5105038926","display_name":"Laurence F\u00e9nart","orcid":"https://orcid.org/0000-0001-9285-0579","observed_orcids":["https://orcid.org/0000-0001-9285-0579"]},"institutions":[{"id":"https://openalex.org/I154526488","display_name":"Inserm","ror":"https://ror.org/02vjkv261","country_code":"FR","type":"government","lineage":["https://openalex.org/I154526488"]},{"id":"https://openalex.org/I157536573","display_name":"Institut Pasteur","ror":"https://ror.org/0495fxg12","country_code":"FR","type":"nonprofit","lineage":["https://openalex.org/I157536573"]},{"id":"https://openalex.org/I2800921988","display_name":"Institut Pasteur de Lille","ror":"https://ror.org/05k9skc85","country_code":"FR","type":"facility","lineage":["https://openalex.org/I2800921988"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Laurence Fenart","raw_affiliation_strings":["SERLIA, INSERM U.325, Institut Pasteur, Lille, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"SERLIA, INSERM U.325, Institut Pasteur, Lille, France","institution_ids":["https://openalex.org/I154526488","https://openalex.org/I157536573","https://openalex.org/I2800921988"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Romain Chauvet","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I32881790","display_name":"Universit\u00e9 de Poitiers","ror":"https://ror.org/04xhy8q59","country_code":"FR","type":"education","lineage":["https://openalex.org/I32881790"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Romain Chauvet","raw_affiliation_strings":["Laboratoire de Pharmacie Gal\u00e9nique et Biopharmacie UPRES EA 1223, 34, rue du Jardin des Plantes, 86000, Poitiers, France","Laboratoire de Pharmacie Gal\u00e9nique et Biopharmacie UPRES EA 1223, Poitiers, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Laboratoire de Pharmacie Gal\u00e9nique et Biopharmacie UPRES EA 1223, 34, rue du Jardin des Plantes, 86000, Poitiers, France","institution_ids":["https://openalex.org/I32881790"]},{"raw_affiliation_string":"Laboratoire de Pharmacie Gal\u00e9nique et Biopharmacie UPRES EA 1223, Poitiers, France","institution_ids":["https://openalex.org/I32881790"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109125400","display_name":"Claudine Pariat","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I32881790","display_name":"Universit\u00e9 de Poitiers","ror":"https://ror.org/04xhy8q59","country_code":"FR","type":"education","lineage":["https://openalex.org/I32881790"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Claudine Pariat","raw_affiliation_strings":["Laboratoire de Pharmacie Gal\u00e9nique et Biopharmacie UPRES EA 1223, 34, rue du Jardin des Plantes, 86000, Poitiers, France","Laboratoire de Pharmacie Gal\u00e9nique et Biopharmacie UPRES EA 1223, Poitiers, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Laboratoire de Pharmacie Gal\u00e9nique et Biopharmacie UPRES EA 1223, 34, rue du Jardin des Plantes, 86000, Poitiers, France","institution_ids":["https://openalex.org/I32881790"]},{"raw_affiliation_string":"Laboratoire de Pharmacie Gal\u00e9nique et Biopharmacie UPRES EA 1223, Poitiers, France","institution_ids":["https://openalex.org/I32881790"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109294156","display_name":"Rom\u00e9o Cecchelli","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I56067802","display_name":"Universit\u00e9 de Rennes","ror":"https://ror.org/015m7wh34","country_code":"FR","type":"education","lineage":["https://openalex.org/I56067802"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Rom\u00e9o Cecchelli","raw_affiliation_strings":["Universit\u00e9 des Sciences, Facult\u00e9 Jean Perrin, Lens, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Universit\u00e9 des Sciences, Facult\u00e9 Jean Perrin, Lens, France","institution_ids":["https://openalex.org/I56067802"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5013386771","display_name":"William R. Couet","orcid":"https://orcid.org/0000-0002-7116-8965","observed_orcids":["https://orcid.org/0000-0002-7116-8965"]},"institutions":[{"id":"https://openalex.org/I32881790","display_name":"Universit\u00e9 de Poitiers","ror":"https://ror.org/04xhy8q59","country_code":"FR","type":"education","lineage":["https://openalex.org/I32881790"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"William Couet","raw_affiliation_strings":["Laboratoire de Pharmacie Gal\u00e9nique et Biopharmacie UPRES EA 1223, 34, rue du Jardin des Plantes, 86000, Poitiers, France","Laboratoire de Pharmacie Gal\u00e9nique et Biopharmacie UPRES EA 1223, Poitiers, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Laboratoire de Pharmacie Gal\u00e9nique et Biopharmacie UPRES EA 1223, 34, rue du Jardin des Plantes, 86000, Poitiers, France","institution_ids":["https://openalex.org/I32881790"]},{"raw_affiliation_string":"Laboratoire de Pharmacie Gal\u00e9nique et Biopharmacie UPRES EA 1223, Poitiers, France","institution_ids":["https://openalex.org/I32881790"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":5,"corresponding_author_ids":["https://openalex.org/A5102751761"],"corresponding_institution_ids":["https://openalex.org/I32881790"],"apc_list":{"value":4690,"currency":"USD","value_usd":4690},"apc_paid":null,"fwci":3.5782,"has_fulltext":false,"cited_by_count":212,"citation_normalized_percentile":{"value":0.92463182,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":95,"max":100},"biblio":{"volume":"16","issue":"12","first_page":"1836","last_page":"1842"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10063","display_name":"Nanoparticle-Based Drug Delivery","score":0.8598999977111816,"subfield":{"id":"https://openalex.org/subfields/2502","display_name":"Biomaterials"},"field":{"id":"https://openalex.org/fields/25","display_name":"Materials Science"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},"topics":[{"id":"https://openalex.org/T10063","display_name":"Nanoparticle-Based Drug Delivery","score":0.8598999977111816,"subfield":{"id":"https://openalex.org/subfields/2502","display_name":"Biomaterials"},"field":{"id":"https://openalex.org/fields/25","display_name":"Materials Science"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T10920","display_name":"Advanced Drug Delivery Systems","score":0.094200000166893,"subfield":{"id":"https://openalex.org/subfields/3003","display_name":"Pharmaceutical Science"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11872","display_name":"Barrier Structure and Function Studies","score":0.028200000524520874,"subfield":{"id":"https://openalex.org/subfields/2808","display_name":"Neurology"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/dalargin","display_name":"dalargin","score":0.9039999842643738},{"id":"https://openalex.org/keywords/polybutylcyanoacrylate-nanoparticles","display_name":"polybutylcyanoacrylate nanoparticles","score":0.9509999752044678},{"id":"https://openalex.org/keywords/tween-80","display_name":"Tween 80","score":0.921999990940094},{"id":"https://openalex.org/keywords/drug-delivery-to-the-brain","display_name":"brain drug delivery","score":0.5809999704360962},{"id":"https://openalex.org/keywords/blood-brain-barrier-permeabilization","display_name":"blood-brain barrier permeabilization","score":0.9750000238418579},{"id":"https://openalex.org/keywords/analgesic-peptides","display_name":"analgesic peptides","score":0.7289999723434448},{"id":"https://openalex.org/keywords/nanoparticle-toxicity","display_name":"nanoparticle toxicity","score":0.9129999876022339},{"id":"https://openalex.org/keywords/polystyrene-nanoparticles","display_name":"polystyrene nanoparticles","score":0.8109999895095825},{"id":"https://openalex.org/keywords/brain-microvascular-endothelial-cells","display_name":"brain microvascular endothelial cells","score":0.8040000200271606},{"id":"https://openalex.org/keywords/astrocytes","display_name":"astrocytes","score":0.9259999990463257},{"id":"https://openalex.org/keywords/locomotor-activity","display_name":"locomotor activity","score":0.8040000200271606}],"concepts":[{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.6685981750488281},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.638975203037262},{"id":"https://openalex.org/C29730261","wikidata":"https://www.wikidata.org/wiki/Q274160","display_name":"Toxicity","level":2,"score":0.6363711953163147},{"id":"https://openalex.org/C2777897440","wikidata":"https://www.wikidata.org/wiki/Q417074","display_name":"Polysorbate","level":3,"score":0.6030415892601013},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.4534275233745575},{"id":"https://openalex.org/C155672457","wikidata":"https://www.wikidata.org/wiki/Q61231","display_name":"Nanoparticle","level":2,"score":0.4168214499950409},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.40564969182014465},{"id":"https://openalex.org/C171250308","wikidata":"https://www.wikidata.org/wiki/Q11468","display_name":"Nanotechnology","level":1,"score":0.18967318534851074},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.1690455973148346},{"id":"https://openalex.org/C58226133","wikidata":"https://www.wikidata.org/wiki/Q1324199","display_name":"Pulmonary surfactant","level":2,"score":0.1616479456424713},{"id":"https://openalex.org/C192562407","wikidata":"https://www.wikidata.org/wiki/Q228736","display_name":"Materials science","level":0,"score":0.1363106667995453},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.12391409277915955}],"mesh":[{"descriptor_ui":"D000700","descriptor_name":"Analgesics","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D000700","descriptor_name":"Analgesics","qualifier_ui":"Q000633","qualifier_name":"toxicity","is_major_topic":false},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001812","descriptor_name":"Blood-Brain Barrier","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D001921","descriptor_name":"Brain","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D002478","descriptor_name":"Cells, Cultured","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002851","descriptor_name":"Chromatography, High Pressure Liquid","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004659","descriptor_name":"Enbucrilate","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D004659","descriptor_name":"Enbucrilate","qualifier_ui":"Q000633","qualifier_name":"toxicity","is_major_topic":true},{"descriptor_ui":"D004727","descriptor_name":"Endothelium","qualifier_ui":"Q000166","qualifier_name":"cytology","is_major_topic":false},{"descriptor_ui":"D004727","descriptor_name":"Endothelium","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D005079","descriptor_name":"Excipients","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D005079","descriptor_name":"Excipients","qualifier_ui":"Q000633","qualifier_name":"toxicity","is_major_topic":true},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008863","descriptor_name":"Microspheres","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009043","descriptor_name":"Motor Activity","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D010147","descriptor_name":"Pain Measurement","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D011136","descriptor_name":"Polysorbates","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D011136","descriptor_name":"Polysorbates","qualifier_ui":"Q000633","qualifier_name":"toxicity","is_major_topic":true},{"descriptor_ui":"D016308","descriptor_name":"Enkephalin, Leucine-2-Alanine","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D016308","descriptor_name":"Enkephalin, Leucine-2-Alanine","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":false},{"descriptor_ui":"D016308","descriptor_name":"Enkephalin, Leucine-2-Alanine","qualifier_ui":"Q000633","qualifier_name":"toxicity","is_major_topic":false},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":3,"locations":[{"id":"doi:10.1023/a:1018947208597","doi":"https://doi.org/10.1023/a:1018947208597","is_oa":false,"landing_page_url":"https://doi.org/10.1023/a:1018947208597","pdf_url":null,"source":{"id":"https://openalex.org/S103865650","display_name":"Pharmaceutical Research","issn_l":"0724-8741","issn":["0724-8741","1573-904X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-70","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319900","host_organization_name":"Springer Science+Business Media","host_organization_lineage":["https://openalex.org/P4310319900","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Science+Business Media","Springer Nature"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pharmaceutical Research","raw_type":"journal-article"},{"id":"pmid:10644071","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/10644071","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pharmaceutical research","raw_type":"Journal Article"},{"id":"pmh:oai:HAL:hal-00534822v1","doi":null,"is_oa":false,"landing_page_url":"https://univ-artois.hal.science/hal-00534822","pdf_url":null,"source":{"id":"https://openalex.org/S4306402512","display_name":"HAL","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4405252976","host_organization_name":"Centre pour la Communication Scientifique Directe","host_organization_lineage":["https://openalex.org/I4405252976"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Pharmaceutical Research, 1999, 16 (12), p. 1836-1842. ⟨10.1023/A:1018947208597⟩","raw_type":"info:eu-repo/semantics/article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9789000153541565,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":28,"referenced_works":["https://openalex.org/W1528488968","https://openalex.org/W1972601090","https://openalex.org/W1972616939","https://openalex.org/W1986129921","https://openalex.org/W1986201693","https://openalex.org/W1989663862","https://openalex.org/W1998302888","https://openalex.org/W2005572462","https://openalex.org/W2007589760","https://openalex.org/W2010755499","https://openalex.org/W2021752742","https://openalex.org/W2026482608","https://openalex.org/W2027568211","https://openalex.org/W2038944069","https://openalex.org/W2040993120","https://openalex.org/W2043530935","https://openalex.org/W2053312409","https://openalex.org/W2055137108","https://openalex.org/W2056272101","https://openalex.org/W2062235656","https://openalex.org/W2082457407","https://openalex.org/W2091282668","https://openalex.org/W2108207203","https://openalex.org/W2134747974","https://openalex.org/W2206043426","https://openalex.org/W2415997377","https://openalex.org/W2473884936","https://openalex.org/W2623436983"],"related_works":["https://openalex.org/W1553061387","https://openalex.org/W2473884936","https://openalex.org/W2415370583","https://openalex.org/W2025595011","https://openalex.org/W2032381925","https://openalex.org/W2056272101","https://openalex.org/W2037054667","https://openalex.org/W2015859925","https://openalex.org/W2068492781","https://openalex.org/W2057958245"],"abstract_inverted_index":null,"counts_by_year":[{"year":2025,"cited_by_count":3},{"year":2024,"cited_by_count":8},{"year":2023,"cited_by_count":5},{"year":2022,"cited_by_count":4},{"year":2021,"cited_by_count":3},{"year":2020,"cited_by_count":9},{"year":2019,"cited_by_count":7},{"year":2018,"cited_by_count":6},{"year":2017,"cited_by_count":4},{"year":2016,"cited_by_count":12},{"year":2015,"cited_by_count":9},{"year":2014,"cited_by_count":9},{"year":2013,"cited_by_count":15},{"year":2012,"cited_by_count":14}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}